VASOTEC Drug Patent Profile
✉ Email this page to a colleague
When do Vasotec patents expire, and what generic alternatives are available?
Vasotec is a drug marketed by Biovail Labs Intl and Bausch and is included in two NDAs.
The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vasotec
A generic version of VASOTEC was approved as enalapril maleate by HERITAGE PHARMA on August 22nd, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VASOTEC?
- What are the global sales for VASOTEC?
- What is Average Wholesale Price for VASOTEC?
Summary for VASOTEC
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 8 |
| Patent Applications: | 3,467 |
| Drug Prices: | Drug price information for VASOTEC |
| What excipients (inactive ingredients) are in VASOTEC? | VASOTEC excipients list |
| DailyMed Link: | VASOTEC at DailyMed |
Recent Clinical Trials for VASOTEC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Novartis Pharmaceuticals | Phase 4 |
| Brigham and Women's Hospital | Phase 4 |
| University of Wisconsin, Madison | Phase 4 |
Pharmacology for VASOTEC
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
US Patents and Regulatory Information for VASOTEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-005 | Jul 26, 1988 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VASOTEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-003 | Dec 24, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for VASOTEC
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Proveca Pharma Limited | Aqumeldi | Enalapril maleate | EMEA/H/C/005731 Treatment of heart failure. |
Authorised | no | no | no | 2023-11-15 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for VASOTEC
See the table below for patents covering VASOTEC around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Bulgaria | 39466 | METHOD FOR PREPARING OF CARBOXYALKYL DIPEPTIDES | ⤷ Sign Up |
| Croatia | P940132 | PROCESS FOR THE PREPARATION OF CARBOXYALKYLDEPEPTIDE DERIVATIVES | ⤷ Sign Up |
| Hong Kong | 27487 | CARBOXYALKYL DIPEPTIDE DERIVATIVES,PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
